title: Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone).
abstract: Based on the discovery of coenzyme Q (CoQ) as an obligatory cofactor for H(+) transport by uncoupling protein 1 (UCP1) [Echtay, K. S., Winkler, E. & Klingenberg, M. (2000) Nature (London) 408, 609-613] we show here that UCP2 and UCP3 are also highly active H(+) transporters and require CoQ and fatty acid for H(+) transport, which is inhibited by low concentrations of nucleotides. CoQ is proposed to facilitate injection of H(+) from fatty acid into UCP. Human UCP2 and 3 expressed in Escherichia coli inclusion bodies are solubilized, and by exchange of sarcosyl against digitonin, nucleotide binding as measured with 2'-O-[5-(dimethylamino)naphthalene-1-sulfonyl]-GTP can be restored. After reconstitution into vesicles, Cl(-) but no H(+) are transported. The addition of CoQ initiates H(+) transport in conjunction with fatty acids. This increase is fully sensitive to nucleotides. The rates are as high as with reconstituted UCP1 from mitochondria. Maximum activity is at a molar ratio of 1:300 of CoQ:phospholipid. In UCP2 as in UCP1, ATP is a stronger inhibitor than ADP, but in UCP3 ADP inhibits more strongly than ATP. Thus UCP2 and UCP3 are regulated differently by nucleotides, in line with their different physiological contexts. These results confirm the regulation of UCP2 and UCP3 by the same factors CoQ, fatty acids, and nucleotides as UCP1. They supersede reports that UCP2 and UCP3 may not be H(+) transporters.
authors.affiliation: Institute for Physiological Chemistry, University of Munich, Schillerstrasse 44, D-80336 Munich, Germany.
authors.forename: K S
authors.initials: KS
authors.lastname: Echtay
authors.forename: E
authors.initials: E
authors.lastname: Winkler
authors.forename: K
authors.initials: K
authors.lastname: Frischmuth
authors.forename: M
authors.initials: M
authors.lastname: Klingenberg
mesh_terms: D000818:Animals; D016227:Benzoquinones / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism*; D003067:Coenzymes; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D006859:Hydrogen / Q000378:metabolism*; D002479:Inclusion Bodies; D007473:Ion Channels; D026901:Membrane Transport Proteins; D024101:Mitochondrial Proteins; D009711:Nucleotides; D011506:Proteins / Q000378:metabolism*; D013329:Structure-Activity Relationship; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000378:metabolism*; D000071246:Uncoupling Protein 2; D000071247:Uncoupling Protein 3
chemical_list: D016227:Benzoquinones; D002352:Carrier Proteins; D003067:Coenzymes; D005227:Fatty Acids; D007473:Ion Channels; D026901:Membrane Transport Proteins; D024101:Mitochondrial Proteins; D009711:Nucleotides; D011506:Proteins; C000604389:UCP2 protein, human; C000604392:UCP3 protein, human; D000071246:Uncoupling Protein 2; D000071247:Uncoupling Protein 3; C032165:ubiquinone 6; D014451:Ubiquinone; C109863:ubiquinone-O; D006859:Hydrogen; C024989:coenzyme Q10; C025204:Ubiquinone Q2; C025203:Ubiquinone Q1